Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 16;4(3):ofx176.
doi: 10.1093/ofid/ofx176. eCollection 2017 Summer.

Prevalence of Carbapenem-Resistant Gram-Negative Infections in the United States Predominated by Acinetobacter baumannii and Pseudomonas aeruginosa

Bin Cai  1 , Roger Echols  2 , Glenn Magee  3 , Juan Camilo Arjona Ferreira  1 , Gareth Morgan  1 , Mari Ariyasu  4 , Takuko Sawada  4 , Tsutae Den Nagata  4
Affiliations

Prevalence of Carbapenem-Resistant Gram-Negative Infections in the United States Predominated by Acinetobacter baumannii and Pseudomonas aeruginosa

Bin Cai et al. Open Forum Infect Dis. .

Abstract

Background: Carbapenem-resistant (CR) Gram-negative pathogens are recognized as a major health concern. This study examined the prevalence of infections due to 4 CR Gram-negative species (Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli) in the United States and assessed their impact on hospital stays and mortality.

Methods: Hospitalized patients with laboratory-confirmed infection due to any of the 4 Gram-negative pathogens were identified from the Premier Healthcare Database. Proportions of CR were calculated by pathogen and infection site (blood, respiratory, urinary, or other) for the United States as whole and by census regions. Crude and adjusted odds ratios for in-hospital mortality were produced using logistic regression.

Results: From 2009 to 2013, 13 262 (4.5%) of 292 742 infections due to these 4 Gram-negative pathogens were CR. Of these CR infections, 82.3% were caused by A. baumannii (22%) or P. aeruginosa (60.3%), while 17.7% were caused by K. pneumoniae or E. coli. CR patients had longer hospital stays than carbapenem-susceptible (CS) patients in all pathogen-infection site cohorts, except in the A. baumannii-respiratory cohort. The crude all cause in-hospital mortality was greater for most pathogen-infection site cohorts of the CR group compared with the CS group, especially for A. baumannii infection in the blood (crude odds ratio [OR], 3.91; 95% confidence interval [CI], 2.69-5.70). This difference for the A. baumannii-blood cohort remained after adjusting for the relevant covariates (adjusted OR, 2.46; 95% CI, 1.43-4.22).

Conclusion: The majority of CR infections and disease burden in the United States was caused by nonfermenters A. baumannii and P. aeruginosa. Patients with CR infections had longer hospital stays and higher crude in-hospital mortality.

Keywords: CRE; Gram-negative; carbapenem resistance; in-hospital mortality; length of stay; nonfermenters.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Carbapenem resistance rate by pathogen-infection site cohort.
See this image and copyright information in PMC

References

    1. Kim YJ, Jun YH, Kim YR et al. . Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy. BMC Infect Dis 2014; 14:161. - PMC - PubMed
    1. Magiorakos AP, Suetens C, Monnet DL et al. . The rise of carbapenem resistance in Europe: just the tip of the iceberg? Antimicrob Resist Infect Control 2013; 2:6. - PMC - PubMed
    1. Ny P, Nieberg P, Wong-Beringer A. Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections. Am J Infect Control 2015; 43:1076–80. - PubMed
    1. Xu A, Zheng B, Xu YC et al. . National epidemiology of carbapenem-resistant and extensively drug-resistant Gram-negative bacteria isolated from blood samples in China in 2013. Clin Microbiol Infect 2016; 22(Suppl 1:S1–8. - PubMed
    1. US Department of Health and Human Services, Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013 Available at: https://www.cdc.gov/drugresistance/pdf/ar-threats-2013–508.pdf. Accessed January 10, 2017.

LinkOut - more resources